Psychedelics - Spark Newswire

1 minute read

Jefferies Global Healthcare Conference: Three Psychedelic Biotech Companies To Participate This Week

Today, 1:09 PM

The 2022 Jefferies Global Healthcare Conference is an annual gathering where over 500 public & private healthcare companies and 3,000 leading executives, institutional investors, private equity investors & VCs address near-term and long-term investment opportunities and discuss current trends driving healthcare in the U.S. and internationally.

DMTTF

2 minute read

Addiction Relapse Prevention: Nirvana Pre-Clinical Study Suggests Psilocybin Could Help Heroin Addiction

By Lara Goldstein

Today, 1:09 PM

Nirvana Life Sciences Inc. (CSE: NIRV) is a Canadian-based life sciences company that develops novel therapeutic products derived from psychedelics to produce non-addictive solutions for opioid addiction treatment and ongoing pain management. Nirvana has recently joined forces with Integrative Therapy Discovery (ITD) Labs of Italy.

CSE:NIRV

2 minute read

Incannex Reveals Clinical Trial Results On Dronabinol-Based Drug For Obstructive Sleep Apnea

By Vuk Zdinjak

Today, 1:09 PM

Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL), a clinical-stage pharmaceutical company developing medicinal cannabinoid pharmaceutical products and psychedelic medicine therapies for unmet medical needs, has completed an analysis of data from the Phase 2 proof-of-concept clinical trial invest

IXHL

3 minute read

These 18 Clinical Trials Could Shape The Future Of The Psychedelics Industry

By Natan Ponieman

Today, 1:09 PM

In the nascent industry of medical psychedelics, drug development is the name of the game. This subset of biotech, poised to become a $100 billion industry according to Canaccord Genuity, bases its success on the regulation and approval of scheduled psychoactive substances for mental health and other health indications.

ATAI

2 minute read

SciSparc & Clearmind Medicine Team Up On Patent For Psychedelic Combination To Treat Cocaine Addiction

By Vuk Zdinjak

Today, 1:09 PM

SciSparc Ltd. (NASDAQ: SPRC) collaboration with Clearmind Medicine Inc. (OTCPK:CMNDF) (CSE:CMND) (FSE:CWY0) resulted in the filing of a provisional patent application related to treating cocaine addiction.

CMNDF

2 minute read

Patricia Arquette Joins Cann For Pride Campaign, Talks About Growing Up And Cannabis Influence

By Nicolas Jose Rodriguez

Today, 1:09 PM

Patricia Arquette is joining Sarah Michelle Gellar, RuPaul’s Drag Race’s Willow Pillow, Kornbread and musicians Kesha and Hayley Kiyoko in a new media campaign for Cann, a cannabis beverage company.

MAPS

2 minute read

Ehave Partners With Halugen Life Sciences To Create A Ketamine Precision Medicine Platform For Clinical Research

By Lara Goldstein

Today, 1:09 PM

Ehave, Inc. (OTC Pink: EHVVF) is a leading healthcare services and technology company focused on progressing psychedelics to therapeutics by engineering novel compounds and new treatment protocols for treating brain health.

EHVVF

1 minute read

Patent For Psychedelic-Based Alcohol Substitute Approved In India, Produced By Clearmind Medicine

By Lara Goldstein

Today, 1:09 PM

India's Office of the Controller-General of Patents, Designs and Trademarks granted approval for a new compound created by the biotech company Clearmind Medicine Inc. (OTC Pink: CMNDF).

CMNDF

2 minute read

Major Depressive Disorder Could Soon Have Treatment Option Via Cybin’s Psilocybin Analog

By Lara Goldstein

Today, 1:09 PM

Cybin Inc. (CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics," has submitted an Investigational New Drug (or “IND”) application to the FDA.

CYBN

2 minute read

Silo Wellness To Acquire Canadian Dyscovry Science, Producer Of Psilocybin For IBS Treatment

By Lara Goldstein

Today, 1:09 PM

Silo Wellness (SILFF), a growth-oriented holding company focused on functional mushroom and psychedelic opportunities, has presented a nonbinding letter of intent to fully acquire Dyscovry Science Ltd.

SILFF